BioSpace News Archive

Conference Call Scheduled for today, August 15, 2019 at 5:00pm ET

Nationwide provider of personalized healthcare expands to Bloomingdale, Illinois

We are pleased to have attracted two experienced executives from the medical device industry who will bring a wealth of relevant expertise

Competition open to data analytics, mathematics and statistics students, and professionals worldwide

The activL Artificial Disc is designed to preserve motion at the treated level of the spine by replicating the performance of the intact intervertebral disc.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways.

The Edogawa NICHE Committee announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells which has heralded the birth of a new chapter in the fight against cancer.

Isofol Medical AB announced the appointment of Roger Tell, M.D., Ph.D. as Chief Medical Officer (CMO), in addition to his responsibilities as Chief Scientific Officer (CSO).

CStone Pharmaceuticals, a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and molecularly-targeted drugs for the treatment of cancer, released its recent business highlights and financial results for the first half of 2019.

111, Inc. announced its unaudited financial results for the second quarter ended June 30, 2019 and US$10 million share repurchase program.